tests of 187 other patients with acute myelogenous leukemia found that none had the eight new mutations found in the first patient.

其他187例急性髓细胞性白血病患者的实验中，均没有发现第一例病人中发现的8个新的基因突变。

acute myelogenous leukemia (aml) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.

急性骨髓性白血病（aml）是指血液中和骨髓中的细胞发生了癌变——骨髓是指骨内作为造血场所的海绵组织。

cyclophosphamide, which can increase risk for chronic heart failure, myelodysplastic syndromes and acute myelogenous leukemia (aml).

可增加患慢性心功能衰竭、骨髓增生异常综合癥和急性粒细胞白血病（aml）的风险。

at high power, the bone marrow of a patient with acute myelogenous leukemia is seen here. there is one lone megakaryocyte at the right center.

在高倍镜下，见到的是急性髓母细胞白血病骨髓。在右侧中心处有一个孤立巨核细胞。

in an embodiment of the first aspect, the acute myelogenous leukemia is relapsed acute myelogenous leukemia.

在第一方面的实施方案中，所述急性髓性白血病是复发性急性髓性白血病。

acute lymphocytic leukemia and acute myelogenous leukemia are each composed of blast cells, known as lymphoblasts or myeloblasts.

急性淋巴细胞白血病和急性粒细胞性白血病均由癌变的母细胞引起，如淋巴母细胞或原始粒细胞。

in acute myelogenous leukemia (aml) and acute lymphocytic leukemia (all), the original acute leukemia cell goes on to form about a trillion more leukemia cells.

在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。

objective to investigate the changes of serum vegf and se-cad levels in patients with acute myelogenous leukemia after treatment.

目的探讨了急性髓系白血病患者治疗前后血清vegf和se-cad水平的变化。

objective to explore the clinical and biological features, prognostic factors and individualized treatment regimen of acute myelogenous leukemia patients over 70 years old.

目的探讨70岁以上老年急性髓性白血病临床及生物学特征、影响预后的因素及个体化治疗方案。

this gs case is unusual because of the disease happened after 12 years of aml remission in a patient considered to have been in remission of acute myelogenous leukemia (aml) for twelve years.

本病例曾患急性骨髓性白血病，并经治疗且疾病缓解十二年后，在子宫颈上发生颗粒性白血球肉瘤，因此更显此病例特殊之处。